Once these pro-inflammatory mediators are activated, they may not only damage the β-cells but can also diminish the potential capacity of remaining β-cells to secrete adequate amount of insulin according to the requirement of blood glucose in both types of diabetes [10]. This evidence concerns the gene INS and diabetes mellitus.